Anixa Biosciences, Inc. (ANIX)
3.625
-0.08
(-2.29%)
USD |
NASDAQ |
Aug 24, 16:00
3.62
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences Shareholders Equity (Quarterly) : 14.48M for April 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 14.48M |
| January 31, 2026 | 15.08M |
| October 31, 2025 | 15.16M |
| July 31, 2025 | 16.60M |
| April 30, 2025 | 16.07M |
| January 31, 2025 | 17.85M |
| October 31, 2024 | 20.00M |
| July 31, 2024 | 21.77M |
| April 30, 2024 | 23.62M |
| January 31, 2024 | 24.60M |
| October 31, 2023 | 24.34M |
| July 31, 2023 | 25.52M |
| April 30, 2023 | 26.81M |
| January 31, 2023 | 27.79M |
| October 31, 2022 | 29.05M |
| July 31, 2022 | 31.70M |
| April 30, 2022 | 32.17M |
| January 31, 2022 | 33.96M |
| October 31, 2021 | 35.44M |
| July 31, 2021 | 36.47M |
| April 30, 2021 | 37.61M |
| January 31, 2021 | 13.60M |
| October 31, 2020 | 8.761M |
| July 31, 2020 | 8.618M |
| April 30, 2020 | 5.287M |
| Date | Value |
|---|---|
| January 31, 2020 | 5.445M |
| October 31, 2019 | 5.235M |
| July 31, 2019 | 5.799M |
| April 30, 2019 | 6.543M |
| January 31, 2019 | 5.479M |
| October 31, 2018 | 5.435M |
| July 31, 2018 | 6.326M |
| April 30, 2018 | 6.066M |
| January 31, 2018 | 6.436M |
| October 31, 2017 | 7.923M |
| July 31, 2017 | 5.488M |
| April 30, 2017 | 3.589M |
| January 31, 2017 | -3.819M |
| October 31, 2016 | 0.9875M |
| July 31, 2016 | 1.718M |
| April 30, 2016 | 2.560M |
| January 31, 2016 | 3.591M |
| October 31, 2015 | 5.054M |
| July 31, 2015 | 5.998M |
| April 30, 2015 | 6.990M |
| January 31, 2015 | 8.258M |
| October 31, 2014 | 4.010M |
| July 31, 2014 | 5.150M |
| April 30, 2014 | 0.1544M |
| January 31, 2014 | -0.6694M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Vicapsys Life Sciences, Inc. | -3.549M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.86M |
| Total Liabilities (Quarterly) | 1.641M |
| Debt to Equity Ratio | 0.0127 |
| Current Ratio | 9.788 |
| Net Debt Paydown Yield | 0.01% |